Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis There is a need for industry-independent decision tools that integrate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results